Back to Archived Journals » Virus Adaptation and Treatment
Virus Adaptation and Treatment ceased publishing in May 2018. All articles that have been published in Virus Adaptation and Treatment will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
![](https://www.dovepress.com/cr_data/cache/journal_image/60/cope/thumb_100_1000_100.jpg)
Virus Adaptation and Treatment
ISSN: 1179-1624
- View all (53)
- Volume 10, 2018 (2)
- Volume 9, 2017 (4)
- Volume 8, 2016 (2)
- Volume 7, 2015 (5)
- Volume 6, 2014 (3)
- Volume 5, 2013 (2)
- Volume 4, 2012 (9)
- Volume 3, 2011 (8)
- Volume 2, 2010 (15)
- Volume 1, 2009 (3)
Journal Articles:
- 53 records -
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Mayaro virus: the jungle flu
![](cr_data/cache/submission_images/s128000/128711/08_jan_2018_figure-1_200_200_90.jpg)
Izurieta RO, DeLacure DA, Izurieta A, Hoare IA, Reina Ortiz M
Virus Adaptation and Treatment 2018, 10:9-17
Published Date: 11 April 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management strategies of enterovirus D68 outbreaks: current perspectives
Milhano N, Borge KS, Bragstad K, Dudman SG
Virus Adaptation and Treatment 2018, 10:1-7
Published Date: 13 March 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lujo virus: current concepts
Sewlall NH, Paweska JT
Virus Adaptation and Treatment 2017, 9:41-47
Published Date: 7 December 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Usutu virus: current knowledge and future perspectives
![](cr_data/cache/submission_images/s123000/123619/17_oct_2017_123619_fig4_200_200_90.jpg)
Saiz JC, Blazquez AB
Virus Adaptation and Treatment 2017, 9:27-40
Published Date: 16 October 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Bovine leukemia virus: current perspectives
Juliarena MA, Barrios CN, Lützelschwab CM, Esteban EN, Gutiérrez SE
Virus Adaptation and Treatment 2017, 9:13-26
Published Date: 10 August 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond
Lucchese G, Kanduc D
Virus Adaptation and Treatment 2017, 9:1-11
Published Date: 1 August 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Phosphorylation of the viral coat protein regulates RNA virus infection
Hoover HS, Kao CC
Virus Adaptation and Treatment 2016, 8:13-20
Published Date: 24 November 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Porcine epidemic diarrhea virus: current insights
Lv C, Xiao Y, Li XD, Tian K
Virus Adaptation and Treatment 2016, 8:1-12
Published Date: 30 May 2016
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recent advances in host–virus interactomics during entry and infection
Bhattacharjee S
Virus Adaptation and Treatment 2015, 7:57-66
Published Date: 1 December 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Impact and differential clinical utility of cobicistat-boosted darunavir in HIV/AIDS
Cossu MV, Astuti N, Capetti A, Rizzardini G
Virus Adaptation and Treatment 2015, 7:47-56
Published Date: 21 August 2015
![Noteworthy comment: A wonderful review of foodborne viruses that will be useful for those who teach the subject of virology.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Viruses of foodborne origin: a review
Todd EC, Greig JD
Virus Adaptation and Treatment 2015, 7:25-45
Published Date: 29 April 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Use of recombinant capsid proteins in the development of a vaccine against the foot-and-mouth disease virus
Belsham GJ, Bøtner A
Virus Adaptation and Treatment 2015, 7:11-23
Published Date: 25 February 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Collection and measurement of aerosols of viable influenza virus in liquid media in an Andersen cascade impactor
Fennelly KP, Tribby MD, Wu CY, Heil GL, Radonovich LJ, Loeb JC, Lednicky JA
Virus Adaptation and Treatment 2015, 7:1-9
Published Date: 17 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Beneficial response of cervical dystonia spasmodic torticollis to cidofovir, an acyclic phosphonate analog (s-1-3-hydroxy-2- phosphonylmethoxypropyl) of cytosine
Lerner AM, Beqaj S
Virus Adaptation and Treatment 2014, 6:33-36
Published Date: 16 September 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Heterogeneous delivery is a barrier to the translational advancement of oncolytic virotherapy for treating solid tumors
Miller AC, Russell SJ
Virus Adaptation and Treatment 2014, 6:11-31
Published Date: 29 July 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Reactivation of latent viruses after treatment with biological therapies
Asthana AK, Lubel JS
Virus Adaptation and Treatment 2014, 6:1-10
Published Date: 20 June 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Schmallenberg virus: continuing a trend?
Noad R, Brownlie J
Virus Adaptation and Treatment 2013, 5:11-19
Published Date: 26 April 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dengue viruses exhibit strain-specific infectivity and entry requirements in vitro
Barr KL, Anderson BD
Virus Adaptation and Treatment 2013, 5:1-9
Published Date: 12 April 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Effect of hepatitis C virus on the central nervous system of HIV-infected individuals
Gess M, Forton D
Virus Adaptation and Treatment 2012, 4:93-106
Published Date: 16 November 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Abortive lytic Epstein–Barr virus replication in tonsil-B lymphocytes in infectious mononucleosis and a subset of the chronic fatigue syndrome
Lerner AM, Beqaj S
Virus Adaptation and Treatment 2012, 4:85-91
Published Date: 8 November 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
New agents for the treatment of hepatitis C virus – focus on telaprevir
Thompson AJ, Patel K
Virus Adaptation and Treatment 2012, 4:75-84
Published Date: 1 November 2012
![Noteworthy comment: In this study, Barr et al. reveal that different serotypes of Dengue virus tend to demonstrate cell-type specific infectivity profiles, despite the fact that there is only a single strain of Dengue. These findings suggest a novel basis explaining the phenomena of co-infection with multiple DENV serotypes and for the observation of co-circulation of multiple DENV serotypes in the same biospace, i.e. in the same individual and/or in a single endemic region. This study provides a new foundation upon which our understanding of dengue virus infection and evolution may be built.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dengue serotypes 1–4 exhibit unique host specificity in vitro
Barr KL, Anderson BD, Heil GL, Friary JA, Gray GC, Focks DA
Virus Adaptation and Treatment 2012, 4:65-73
Published Date: 1 October 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Issues in resistance, adherence, and comparative efficacy of the single-tablet regimen combination of tenofovir, emtricitabine, and efavirenz in the management of HIV-1 infection
Rebick G, Walmsley SL
Virus Adaptation and Treatment 2012, 4:51-63
Published Date: 5 September 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hepatitis C quasispecies adaptation in the setting of a variable fidelity polymerase
Schmidt-Martin D, Crosbie O, Kenny-Walsh E, Fanning LJ
Virus Adaptation and Treatment 2012, 4:43-50
Published Date: 24 July 2012
![Noteworthy comment: This very well written review by Vaughan et al. is an excellent review of cutting edge methods used in the growing field of RNA biology. Both classic and emerging approaches to characterizing interactions between RNA and protein molecules are described. This is a must read for anyone wanting to enter this field.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Mapping protein–RNA interactions
Vaughan R, Running W, Qi R, Kao CC
Virus Adaptation and Treatment 2012, 4:29-41
Published Date: 2 May 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Mononucleosis and Epstein–Barr virus infection: treatment and medication
Valachis A, Kofteridis DP
Virus Adaptation and Treatment 2012, 4:23-28
Published Date: 14 March 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Oncolytic viruses: a step into cancer immunotherapy
Pol JG, Rességuier J, Lichty BD
Virus Adaptation and Treatment 2012, 4:1-21
Published Date: 28 December 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The impact of hypoxia on oncolytic virotherapy
Guo ZS
Virus Adaptation and Treatment 2011, 3:71-82
Published Date: 16 November 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal and update on tenofovir in management of human immunodeficiency virus infection
Alvarez E, Morello J, Soriano V, Labarga P, Rodriguez-Nóvoa S
Virus Adaptation and Treatment 2011, 3:55-69
Published Date: 31 August 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evolution and adaptation of the pandemic A/H1N1 2009 influenza virus
Ducatez MF, Fabrizio TP, Webby RJ
Virus Adaptation and Treatment 2011, 3:45-53
Published Date: 20 July 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The management of herpes simplex virus infections in HIV infected patients: current issues and the role of cidofovir
Nakakawa E, Reynolds SJ
Virus Adaptation and Treatment 2011, 3:35-43
Published Date: 14 June 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical utility and long-term use of atazanavir in the treatment of HIV-1 infection
Rampling T, Nelson M
Virus Adaptation and Treatment 2011, 3:25-34
Published Date: 25 March 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A paradigm linking herpesvirus immediate-early gene expression apoptosis and myalgic encephalomyelitis chronic fatigue syndrome
A Martin Lerner, Safedin Beqaj
Virus Adaptation and Treatment 2011, 3:19-24
Published Date: 21 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Boceprevir in the treatment of chronic hepatitis C virus infection
Marina Berenguer, F Xavier López-Labrador
Virus Adaptation and Treatment 2011, 3:7-17
Published Date: 22 February 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Acyclovir and hydrocortisone cream for the early treatment of recurrent cold sores
Carrie A Sailer, Spotswood L Spruance, Christopher M Hull
Virus Adaptation and Treatment 2011, 3:1-6
Published Date: 11 January 2011
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Viral vectors for cystic fibrosis gene therapy: What does the future hold?
Uta Griesenbach, Makoto Inoue, Mamoru Hasegawa, et al
Virus Adaptation and Treatment 2010, 2:159-171
Published Date: 13 December 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Antibody targeting of TSG101 on influenza-infected cells
Aurelio Bonavia, Leyla S Diaz, David Santos, et al
Virus Adaptation and Treatment 2010, 2:147-157
Published Date: 9 November 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An update on the management of glandular fever (infectious mononucleosis) and its sequelae caused by Epstein–Barr virus (HHV-4): new and emerging treatment strategies
A Martin Lerner, Safedin H Beqaj, Ken Gill, et al
Virus Adaptation and Treatment 2010, 2:135-145
Published Date: 23 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease
J Ortiz-Alcantara, K Bhardwaj, S Palaninathan, et al.
Virus Adaptation and Treatment 2010, 2:125-133
Published Date: 6 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The role of herpesviruses in ocular infections
Asim V Farooq, Arpeet Shah, Deepak Shukla
Virus Adaptation and Treatment 2010, 2:115-123
Published Date: 1 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
p38 and STAT3 activation by vGPCR in KSHV-infected cells
Mingli Liu, Shanchun Guo
Virus Adaptation and Treatment 2010, 2:103-113
Published Date: 6 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The next generation: etravirine in the treatment of HIV-1 infection in adults refractory to other antiretrovirals
R Chris Rathbun, Michelle D Liedtke
Virus Adaptation and Treatment 2010, 2:91-102
Published Date: 9 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies
S Chinnaswamy, H Cai, C Kao
Virus Adaptation and Treatment 2010, 2:73-89
Published Date: 22 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Differential susceptibility of HIV strains to innate immune factors in human cervical-vaginal secretions
Mimi Ghosh, John V Fahey, Charles R Wira
Virus Adaptation and Treatment 2010, 2:63-71
Published Date: 1 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Resistance patterns and genetic variations in patients with hepatitis C virus: emerging role of telaprevir
C Argentini, D Genovese, S Catone
Virus Adaptation and Treatment 2010, 2:59-62
Published Date: 9 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome
A Martin Lerner, Safedin Beqaj, James T Fitzgerald, et al
Virus Adaptation and Treatment 2010, 2:47-57
Published Date: 24 May 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Poxviruses: smallpox vaccine, its complications and chemotherapy
Mimi Remichkova
Virus Adaptation and Treatment 2010, 2:41-46
Published Date: 20 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Conformations of the monomeric hepatitis C virus RNA-dependent RNA polymerase
Sreedhar Chinnaswamy, Ayaluru Murali, Hui Cai, et al
Virus Adaptation and Treatment 2010, 2:21-39
Published Date: 11 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae
Darci R Smith, Monica Ogg, Aura Garrison, et al
Virus Adaptation and Treatment 2010, 2:9-20
Published Date: 26 February 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A method for evaluating antiviral drug susceptibility of Epstein-Barr virus
Charlotte A Romain, Henry H Balfour Jr, Heather E Vezina, et al
Virus Adaptation and Treatment 2010, 2:1-7
Published Date: 25 January 2010